{"entity":{"type":"insider","cik":"0001532235","url":"/insider/0001532235","json_url":"/insider/0001532235.json","name":"Finizio Robert G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":17,"first":"2014-01-23","last":"2021-05-12","span_basis":"filed_date"},"name_variants":[{"name":"Finizio Robert G","source":"filing","n_filings":17,"first_seen":"2014-01-23","last_seen":"2021-05-12"}],"transactions":[{"id":4353425,"accession":"0001387131-21-005565","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-21-005565","line_url":"/filing/0001387131-21-005565#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67697.0,"shares_display":"67,697","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":70404.88,"total_display":"70,404.88","total_whole":"70,405","shares_owned_after":17991637.0,"shares_owned_after_display":"17,991,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider"},{"id":3183766,"accession":"0001387131-20-005580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-20-005580","line_url":"/filing/0001387131-20-005580","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46000.0,"shares_display":"46,000","price_per_share":1.442608695652174,"price_display":"1.44","price_state":"stated","total_value":66360.0,"total_display":"66,360.00","total_whole":"66,360","shares_owned_after":18401964.0,"shares_owned_after_display":"18,401,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider","n_lines":2},{"id":3140566,"accession":"0001387131-20-005521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-20-005521","line_url":"/filing/0001387131-20-005521","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.1533333333333333,"price_display":"1.15","price_state":"stated","total_value":34600.0,"total_display":"34,600.00","total_whole":"34,600","shares_owned_after":18355964.0,"shares_owned_after_display":"18,355,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-08","scope":"insider","n_lines":2},{"id":8014618,"accession":"0001387131-19-007988","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-007988","line_url":"/filing/0001387131-19-007988#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72000.0,"shares_display":"72,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":198000.0,"total_display":"198,000.00","total_whole":"198,000","shares_owned_after":18325964.0,"shares_owned_after_display":"18,325,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-29","scope":"insider"},{"id":8113143,"accession":"0001387131-19-006289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-006289","line_url":"/filing/0001387131-19-006289#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":2.74,"price_display":"2.74","price_state":"stated","total_value":95900.0,"total_display":"95,900.00","total_whole":"95,900","shares_owned_after":18253964.0,"shares_owned_after_display":"18,253,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-20","scope":"insider"},{"id":8364009,"accession":"0001387131-19-006018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-19-006018","line_url":"/filing/0001387131-19-006018#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52405.0,"shares_display":"52,405","price_per_share":2.96,"price_display":"2.96","price_state":"stated","total_value":155118.8,"total_display":"155,118.80","total_whole":"155,119","shares_owned_after":18218964.0,"shares_owned_after_display":"18,218,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":6005283,"accession":"0001387131-18-006984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-006984","line_url":"/filing/0001387131-18-006984#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92910.0,"shares_display":"92,910","price_per_share":3.626,"price_display":"3.63","price_state":"stated","total_value":336891.66,"total_display":"336,891.66","total_whole":"336,892","shares_owned_after":18366559.0,"shares_owned_after_display":"18,366,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-21","scope":"insider"},{"id":6005278,"accession":"0001387131-18-006984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-006984","line_url":"/filing/0001387131-18-006984#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":3.698,"price_display":"3.70","price_state":"stated","total_value":340216.0,"total_display":"340,216.00","total_whole":"340,216","shares_owned_after":18366559.0,"shares_owned_after_display":"18,366,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2018-12-21","scope":"insider"},{"id":6839178,"accession":"0001387131-18-006727","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001387131-18-006727","line_url":"/filing/0001387131-18-006727#line-5","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":4.604,"price_display":"4.60","price_state":"stated","total_value":423568.0,"total_display":"423,568.00","total_whole":"423,568","shares_owned_after":18366559.0,"shares_owned_after_display":"18,366,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-10","scope":"insider"},{"id":6839171,"accession":"0001387131-18-006727","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-18-006727","line_url":"/filing/0001387131-18-006727#line-3","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":4.572,"price_display":"4.57","price_state":"stated","total_value":420624.0,"total_display":"420,624.00","total_whole":"420,624","shares_owned_after":18366559.0,"shares_owned_after_display":"18,366,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-10","scope":"insider"},{"id":6346870,"accession":"0001387131-18-006419","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-006419","line_url":"/filing/0001387131-18-006419#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":4.805,"price_display":"4.80","price_state":"stated","total_value":442060.0,"total_display":"442,060.00","total_whole":"442,060","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-28","scope":"insider"},{"id":6346860,"accession":"0001387131-18-006419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-006419","line_url":"/filing/0001387131-18-006419#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":4.859,"price_display":"4.86","price_state":"stated","total_value":447028.0,"total_display":"447,028.00","total_whole":"447,028","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-26","filed_date":"2018-11-28","scope":"insider"},{"id":6563983,"accession":"0001387131-18-006220","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-006220","line_url":"/filing/0001387131-18-006220#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":4.809,"price_display":"4.81","price_state":"stated","total_value":442428.0,"total_display":"442,428.00","total_whole":"442,428","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-13","filed_date":"2018-11-14","scope":"insider"},{"id":6563980,"accession":"0001387131-18-006220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-006220","line_url":"/filing/0001387131-18-006220#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":4.73,"price_display":"4.73","price_state":"stated","total_value":435160.0,"total_display":"435,160.00","total_whole":"435,160","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-12","filed_date":"2018-11-14","scope":"insider"},{"id":6485499,"accession":"0001387131-18-005729","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-005729","line_url":"/filing/0001387131-18-005729#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":5.117,"price_display":"5.12","price_state":"stated","total_value":470764.0,"total_display":"470,764.00","total_whole":"470,764","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-26","filed_date":"2018-10-29","scope":"insider"},{"id":6485495,"accession":"0001387131-18-005729","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-005729","line_url":"/filing/0001387131-18-005729#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":5.449,"price_display":"5.45","price_state":"stated","total_value":501308.0,"total_display":"501,308.00","total_whole":"501,308","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-25","filed_date":"2018-10-29","scope":"insider"},{"id":6460056,"accession":"0001387131-18-005451","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-005451","line_url":"/filing/0001387131-18-005451#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":5.448,"price_display":"5.45","price_state":"stated","total_value":501216.0,"total_display":"501,216.00","total_whole":"501,216","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-12","filed_date":"2018-10-15","scope":"insider"},{"id":6460050,"accession":"0001387131-18-005451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-005451","line_url":"/filing/0001387131-18-005451#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":5.648,"price_display":"5.65","price_state":"stated","total_value":519616.0,"total_display":"519,616.00","total_whole":"519,616","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-11","filed_date":"2018-10-15","scope":"insider"},{"id":6591067,"accession":"0001387131-18-004940","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-004940","line_url":"/filing/0001387131-18-004940#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":6.67,"price_display":"6.67","price_state":"stated","total_value":613640.0,"total_display":"613,640.00","total_whole":"613,640","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-21","filed_date":"2018-09-24","scope":"insider"},{"id":6591064,"accession":"0001387131-18-004940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-004940","line_url":"/filing/0001387131-18-004940#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":6.58,"price_display":"6.58","price_state":"stated","total_value":605360.0,"total_display":"605,360.00","total_whole":"605,360","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-20","filed_date":"2018-09-24","scope":"insider"},{"id":6839161,"accession":"0001387131-18-004627","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-18-004627","line_url":"/filing/0001387131-18-004627#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":6.22,"price_display":"6.22","price_state":"stated","total_value":572240.0,"total_display":"572,240.00","total_whole":"572,240","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-10","scope":"insider"},{"id":6839153,"accession":"0001387131-18-004627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-18-004627","line_url":"/filing/0001387131-18-004627#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":575000.0,"total_display":"575,000.00","total_whole":"575,000","shares_owned_after":18393559.0,"shares_owned_after_display":"18,393,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-10","scope":"insider"},{"id":7038996,"accession":"0001387131-14-001137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-001137","line_url":"/filing/0001387131-14-001137#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":982053.0,"shares_display":"982,053","price_per_share":6.6971,"price_display":"6.70","price_state":"stated","total_value":6576907.1463,"total_display":"6,576,907.15","total_whole":"6,576,907","shares_owned_after":21029533.0,"shares_owned_after_display":"21,029,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-26","filed_date":"2014-03-28","scope":"insider"},{"id":6685668,"accession":"0001387131-14-000642","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-14-000642","line_url":"/filing/0001387131-14-000642#line-3","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16600.0,"shares_display":"16,600","price_per_share":6.1801,"price_display":"6.18","price_state":"stated","total_value":102589.66,"total_display":"102,589.66","total_whole":"102,590","shares_owned_after":22011586.0,"shares_owned_after_display":"22,011,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-21","filed_date":"2014-02-21","scope":"insider"},{"id":6685665,"accession":"0001387131-14-000642","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-14-000642","line_url":"/filing/0001387131-14-000642#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":6.173,"price_display":"6.17","price_state":"stated","total_value":103089.1,"total_display":"103,089.10","total_whole":"103,089","shares_owned_after":22028186.0,"shares_owned_after_display":"22,028,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-20","filed_date":"2014-02-21","scope":"insider"},{"id":6685654,"accession":"0001387131-14-000642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-000642","line_url":"/filing/0001387131-14-000642#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":6.1681,"price_display":"6.17","price_state":"stated","total_value":103007.27,"total_display":"103,007.27","total_whole":"103,007","shares_owned_after":22044886.0,"shares_owned_after_display":"22,044,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-19","filed_date":"2014-02-21","scope":"insider"},{"id":6416239,"accession":"0001387131-14-000282","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-14-000282","line_url":"/filing/0001387131-14-000282#line-3","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16600.0,"shares_display":"16,600","price_per_share":5.9243,"price_display":"5.92","price_state":"stated","total_value":98343.38,"total_display":"98,343.38","total_whole":"98,343","shares_owned_after":22061586.0,"shares_owned_after_display":"22,061,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-23","filed_date":"2014-01-23","scope":"insider"},{"id":6416236,"accession":"0001387131-14-000282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-14-000282","line_url":"/filing/0001387131-14-000282#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":5.6626,"price_display":"5.66","price_state":"stated","total_value":94565.42,"total_display":"94,565.42","total_whole":"94,565","shares_owned_after":22078186.0,"shares_owned_after_display":"22,078,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-22","filed_date":"2014-01-23","scope":"insider"},{"id":6416233,"accession":"0001387131-14-000282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-000282","line_url":"/filing/0001387131-14-000282#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532235","owner_name":"Finizio Robert G","owner_display_name":"Finizio Robert G","owner_url":"/insider/0001532235","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":5.5282,"price_display":"5.53","price_state":"stated","total_value":92320.94,"total_display":"92,320.94","total_whole":"92,321","shares_owned_after":22094886.0,"shares_owned_after_display":"22,094,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Director, Officer (CEO), Ten percent owner","n_filings":17,"first_seen":"2014-01-23","last_seen":"2021-05-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001532235","retrieved_at":"2026-08-24T12:29:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}